image
Avalo Therapeutics, Inc. AVTX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 12.41
-7.94 %
$ 129 M
Market Cap
0.13
P/E
INCOME STATEMENT
1.92 M REVENUE
-89.34%
Growth Rates
1Year -89.34%
3Years -34.02%
5Years -36.29%
7Years 7.59%
10Years 0.00%
-23.4 M OPERATING INCOME
37.38%
Growth Rates
1Year 37.38%
3Years 4.54%
5Years 9.82%
7Years -5.53%
10Years -6.13%
-31.5 M NET INCOME
24.28%
Growth Rates
1Year 24.28%
3Years 20.80%
5Years 4.66%
7Years -9.73%
10Years -9.23%
EFFICIENCY
Earnings Waterfall Avalo Therapeutics, Inc.
image
Revenue 1.92 M
Cost Of Revenue 1.28 M
Gross Profit 640 K
Operating Expenses 640 K
Operating Income -23.4 M
Other Expenses 8.1 M
Net Income -31.5 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 1.9 18.1 5.4 6.7 6.8 18.3 27.8 1.2 0 0 0 82.8 K
GROSS PROFIT
Cost Of Revenue 1.3 3.4 1.5 0.3 11.6 7.5 0.6 8.2 23.5 K 9.5 0 8.5
Gross Profit 0.6 14.6 3.9 6.4 (4.9) 10.8 27.2 (7.1) 23.5 K (9.5) 0 (8.4)
OPERATING INCOME
Operating Expenses 0.6 52.1 86.0 53.7 24.7 29.5 13.3 17.2 11.0 17.1 12.9 2.1
Selling, General and Administrative Expenses 10.3 20.7 24.7 19.8 11.6 19.2 8.9 7.1 4.4 4.9 4.0 2.1
Research and Development Expenses 13.8 31.3 59.8 32.2 11.8 5.8 4.4 10.2 6.6 12.2 8.9 8.5
Operating Income (23.4) (37.4) (82.1) (27.0) (17.4) (39.3) 13.9 (16.1) (11.0) (17.1) (12.9) (10.5)
PRE-TAX INCOME
Interest Income Expense 3.4 4.2 2.4 0 0 0 0 0 (0.8) (1.2) 10.6 K 0
Total Other Income (8.1) (4.2) (2.4) 5.7 12.3 54.9 K 53.6 K (0.4) 0.5 1.1 (0.1) 1.35 K
Pre-Tax Income (31.5) (41.6) (84.5) (67.2) (16.0) (40.1) 13.8 (16.5) (10.5) (16.1) (13.0) (10.5)
NET INCOME
Tax Provision 14 K 28 K (0.2) (2.8) 0.3 33.9 K 2.0 0.4 (0.5) (1.1) 0.1 0
Net Income (31.5) (41.7) (84.3) (64.4) (16.3) (40.1) 11.9 (16.5) (10.5) (16.1) (13.0) (10.5)
EPS 114 1.06 K 2.33 K 2.52 K 820 3.32 K 1.21 K 5.37 K 13.6 K 0 0 200